China Ai In Oncology Market Size & Outlook, 2023-2030
China ai in oncology market, 2018-2030 (US$M)
Related Markets
China ai in oncology market highlights
- The China ai in oncology market generated a revenue of USD 187.5 million in 2023 and is expected to reach USD 1,456.5 million by 2030.
- The China market is expected to grow at a CAGR of 34% from 2024 to 2030.
- In terms of segment, software solutions was the largest revenue generating component in 2023.
- Software Solutions is the most lucrative component segment registering the fastest growth during the forecast period.
Ai in oncology market data book summary
| Market revenue in 2023 | USD 187.5 million |
| Market revenue in 2030 | USD 1,456.5 million |
| Growth rate | 34% (CAGR from 2023 to 2030) |
| Largest segment | Software solutions |
| Fastest growing segment | Software Solutions |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software Solutions, Hardware, Services |
| Key market players worldwide | International Business Machines Corp, Siemens Healthineers AG ADR, Intel Corp, GE HealthCare Technologies Inc Common Stock, NVIDIA Corp |
Other key industry trends
- In terms of revenue, China accounted for 6.7% of the global ai in oncology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China ai in oncology market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,047.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI In Oncology Market Scope
AI In Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China ai in oncology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai in oncology market will help companies and investors design strategic landscapes.
Software solutions was the largest segment with a revenue share of 50.24% in 2023. Horizon Databook has segmented the China ai in oncology market based on software solutions, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
China is the most populated country globally. Hence, the number of cancer patients is high. Research institutes and market players are thus investing in technological advancements in AI to accelerate the developments in cancer care.
Ongoing research initiatives leverage advancements in ML, image analysis, and data processing to enhance the accuracy & efficiency of AI applications in oncology. These collaborations facilitate the translation of research findings into practical solutions, fostering the integration of AI into clinical practices and healthcare systems.
Reasons to subscribe to China ai in oncology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China ai in oncology market databook
-
Our clientele includes a mix of ai in oncology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China ai in oncology market , including forecasts for subscribers. This country databook contains high-level insights into China ai in oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China ai in oncology market size, by component, 2018-2030 (US$M)
China AI In Oncology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
